重症中毒患者管理中脂肪乳剂治疗:一项前瞻性队列研究
该研究基于毒理学研究者联盟脂肪乳剂子登记处2012年5月至2018年12月的前瞻性队列数据,纳入134例接受静脉脂肪乳剂治疗的重症中毒患者,女性81例(60.4%),中位年龄40岁(四分位距21-75),其中108例(80.6%)存活、45例(33.6%)中毒期间发生心脏骤停、82例(61.2%)低血压、98例(73.1%)接受机械通气。主要结局存活与毒物辛醇-水分配系数对数的线性分析(P=0.89)及多项式模型(P=0.10)均无关联。分配系数对数<3.6组脂肪乳剂给药前收缩压中位数68 mmHg(四分位距60-78) vs 给药后89 mmHg(76-104);>3.6组给药前69 mmHg(60-84) vs 给药后89 mmHg(80-96),两组收缩压均升高。作者结论为多数患者存活,亲脂性与存活或观察到的血压变化不相关,本研究未评估脂肪乳剂的疗效。
要点
- 134例接受静脉脂肪乳剂的重症中毒患者中,108例(80.6%)存活,45例(33.6%)中毒期间发生心脏骤停。
- 存活与毒物辛醇-水分配系数对数的线性分析无关联(P=0.89),多项式模型亦无关联(P=0.10)。
- 分配系数对数<3.6组收缩压中位数由给药前68 mmHg(60-78)升至给药后89 mmHg(76-104)。
- 分配系数对数>3.6组收缩压中位数由给药前69 mmHg(60-84)升至给药后89 mmHg(80-96)。
- 作者指出亲脂性与存活及观察到的血压变化均不相关,且本研究未评估脂肪乳剂的疗效。
适用人群与场景
- 毒理学研究者联盟脂肪乳剂子登记处2012年5月至2018年12月收录的接受静脉脂肪乳剂治疗的重症中毒患者134例。
- 其中女性81例(60.4%),中位年龄40岁(四分位距21-75)。
- 82例(61.2%)低血压,98例(73.1%)接受机械通气,45例(33.6%)中毒期间发生心脏骤停。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入毒理学研究者联盟脂肪乳剂子登记处2012年5月至2018年12月的134例接受静脉脂肪乳剂治疗的重症中毒患者。
- 主要结局存活:108例(80.6%)存活,其中45例(33.6%)中毒期间发生心脏骤停。
- 存活与毒物辛醇-水分配系数对数的关系:线性分析无关联(P=0.89),多项式模型无关联(P=0.10)。
- 分配系数对数<3.6组收缩压中位数(四分位距)由脂肪乳剂给药前68 mmHg(60-78)升至给药后89 mmHg(76-104)。
- 分配系数对数>3.6组收缩压中位数(四分位距)由脂肪乳剂给药前69 mmHg(60-84)升至给药后89 mmHg(80-96)。
- 作者结论:多数患者存活,亲脂性与存活或观察到的血压变化均不相关,本研究未评估脂肪乳剂的疗效。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:本研究未评估脂肪乳剂的疗效;作者自述亲脂性与存活或观察到的血压变化均不相关。
对床旁实践的改变
- 作者认为,本队列中多数接受静脉脂肪乳剂的重症中毒患者存活,但毒物亲脂性与存活及给药后血压变化均不相关。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite conflicting data, intravenous lipid emulsion has emerged as a potential antidote. The "lipid sink" theory suggests that following intravenous administration of lipid, lipophilic drugs are sequestered in the vascular compartment, thereby reducing their tissue concentrations. This study sought to determine if survival is associated with the intoxicant's degree of lipophilicity.
METHODS: We reviewed all cases in the Toxicology Investigators Consortium's lipid sub-registry between May 2012 through December 2018. Information collected included demographics, exposure circumstances, clinical course, management, disposition, and outcome. The primary outcome was survival after lipid emulsion therapy. Survival was stratified by the log of the intoxicant's octanol-water partition coefficient. We also assessed the association between intoxicant lipophilicity and an increase in systolic blood pressure after lipid emulsion administration.
RESULTS: We identified 134 patients, including 81 (60.4%) females. The median age was 40 years (interquartile range 21-75). One hundred and eight (80.6%) patients survived, including 45 (33.6%) with cardiac arrest during their intoxication. Eighty-two (61.2%) were hypotensive, and 98 (73.1%) received mechanical ventilation. There was no relationship between survival and the log of the partition coefficient of the intoxicant on linear analysis (P = 0.89) or polynomial model (P = 0.10). Systolic blood pressure increased in both groups. The median (interquartile range) systolic blood pressure before lipid administration was 68 (60-78) mmHg for those intoxicants with a log partition coefficient < 3.6 compared with 89 (76-104) mmHg after lipid administration. Among those drugs with a log partition coefficient > 3.6, the median (interquartile range) was 69 (60-84) mmHg before lipid and 89 (80-96) mmHg after lipid administration.
CONCLUSION: Most patients in this cohort survived. Lipophilicity was not correlated with survival or the observed changes in blood pressure. The study did not address the efficacy of lipid emulsion.
参考来源
- Levine M, Brent J, Wiegand T, et al. Lipid emulsion therapy during management of the critically-ill poisoned patient: a prospective cohort study. Clin Toxicol (Phila). 2023. PMID: 37655788. doi:10.1080/15563650.2023.2248372
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。